Vimarsana
Biggest News Aggregation in the World

Kryoablation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kryoablation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kryoablation Today - Breaking & Trending Today

Why The Less Invasive Breast Cancer Treatment 'Freezing' Is A Game-Changer For Patients - Vimarsana News

Why The Less Invasive Breast Cancer Treatment 'Freezing' Is A Game-Changer For Patients

It has been learnt that when freezing is combined with hormonal therapy and radiation, patients can have nearly 100 per cent of their tumors destroyed, and if the tumors do return, patients can be treated with cryoablation multiple times to control growth. TheHealthSite.com

New, Less Invasive Breast Cancer Treatment Involving Freezing Could Replace Surgery for Some Patients - Vimarsana News

New, Less Invasive Breast Cancer Treatment Involving Freezing Could Replace Surgery for Some Patients

"For patients who have larger tumors but can't undergo surgery, this approach could be more effective," interventional radiologist Yolanda Bryce, M.D. said

Source: yahoo.com
Immune action at a distance - Vimarsana News

Immune action at a distance

Researchers from MIT and Mass General Brigham developed a gel-based platform for local delivery of drugs into tumors that promises to help treat metastatic cancer.

Source: mit.edu
Substantial Evidence-Based Data Currently Being Generated by 19 Ongoing Studies Using IceCure Medical's ProSense® Cryoablation System - Vimarsana News

Substantial Evidence-Based Data Currently Being Generated by 19 Ongoing Studies Using IceCure Medical's ProSense® Cryoablation System

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that in parallel with the growing adoption of ProSense®, the number of independent, non-sponsored studies of its cryoablation system has significantly increased. In addition to the 12 studies already published in peer reviewed journals and presented in scienti

Source: yahoo.com
Independent Study Validates IceCure's ProSense Cryoablation is Safe & Effective Outpatient Procedure for Breast Cancer with 96.8% Success Rate - Vimarsana News

Independent Study Validates IceCure's ProSense Cryoablation is Safe & Effective Outpatient Procedure for Breast Cancer with 96.8% Success Rate

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that new data was presented at the European Society of Breast Imaging ("EUSOBI") Scientific Meeting in Valencia, Spain by Lucía Graña-López, MD, PhD, principal investigator of the independent, non-sponsored study.

Source: yahoo.com